The leading eye care provider Key-Whitman Eye Center, and Evergaze, the developer and manufacturer of seeBOOST®, announced a partnership designed to better serve patients with low vision.
DALLAS (PRWEB) November 02, 2018
Key-Whitman Eye Center, the recognized leader in eye care for half a century, and Evergaze, the developer and manufacturer of seeBOOST®, announced today a partnership designed to better serve patients with low vision.
The seeBOOST product will be available at Key-Whitman Eye Centers to help patients dealing with a variety of low vision conditions including age-related macular degeneration, diabetic retinopathy, and others. This new offering complements the ocular continuum of care, which many patients need.
"Our clinics provide comprehensive medical eye care for a wide range of vision conditions including cataracts, glaucoma, LASIK, dry eye, and oculofacial cosmetic surgery. Providing the seeBOOST product further enhances our long-standing commitment to providing complete eye care for our advanced stage AMD and diabetic patients," said Dr. Jeffrey Whitman, MD.
"Our new partnership with Key-Whitman and their world-class doctors is an important step towards helping us to fulfill our mission of Vision for Life. Accessibility of seeBOOST within a trusted and integrated ophthalmic/optometric full-service medical clinic will result in better outcomes for patients coping with irreversible vision loss. By providing a continuum of care from a comprehensive state-of-the-art eye exam to the seeBOOST electronic prescription glasses, these patients can regain their functional vision and maintain a higher quality of life," said Don Dias, President of Evergaze.
About Key-Whitman Eye Center
Key-Whitman Eye Center is the largest comprehensive care ophthalmic clinical center with 6 locations in the Metroplex and 16 full-time ophthalmologists and optometrists in Dallas-Fort Worth. Over the course of half a century of service, Key-Whitman earned the reputation as being synonymous with trusted eye care.
Evergaze, the developer and manufacturer of seeBOOST®, pioneered a new category of disease-specific prescription glasses to help those coping with vision loss from AMD and diabetes. The company continues to innovate in developing the world's first non-implanted artificial eye. The company's goal is to eradicate the impact of vision loss through technology, and enable older individuals to benefit from vision for life.
KW PR contact:
Director of Communication